GL1X · GenesisL1 explorer

MolNFT v1 · #113185 · protein

Crystal structure of human JMJD2A in complex with compound 30

5A7Q · Lysine-specific demethylase 4A: “Crystal structure of human JMJD2A in complex with compound 30”. X-ray diffraction, 4 ligands (KCH, MN, ZN), 8 pockets (best druggability 0.74). MolNFT v1 #113185 on GenesisL1: 3D structure, binding…

PDB
5A7Q
Type
protein
Length
697 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysine-specific demethylase 4A
EC
1.14.11.-
UniProt
O75164
Ligands
KCH, MN, ZN, CL
Pockets
8 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysine-specific demethylase 4A (EC 1.14.11.-)protein35130% helix, 24% strandO75164
BLysine-specific demethylase 4A (EC 1.14.11.-)protein34633% helix, 25% strandO75164

Ligands and binding sites

  • KCH · 2-(5-azanyl-2-oxidanyl-phenyl)pyridine-4-carboxylic acid · ligand · 2 copies · chains A, B
  • MN · Manganese (II) ion · metal · 4 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14370.740.8345MN, KCH, CL
24190.730.8341MN, KCH, CL
37020.700.7778CL, EDO
4860.460.8121empty
5610.440.8317empty

Interfaces

1 interface between chains.

  • A–B · 509 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5A7Q · Crystal structure of human JMJD2A in complex with compound 30 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.